The company announced a licensing deal that will allow the drug, molnupiravir, to be made and sold cheaply in 105 developing nations.The company announced a licensing deal that will allow the drug, molnupiravir, to be made and sold cheaply in 105 developing nations.Molnupiravir (Drug), Medicine and Health, Drugs (Pharmaceuticals), Coronavirus (2019-nCoV), Inventions and Patents, Third World and Developing Countries, Medicines Patent Pool Foundation, Merck & Company Inc, Ridgeback Biotherapeutics, Emory UniversityRead More
